Sinovac’s vaccine shows an 80-90% efficacy rate within 2 months after 2 shots: CEO

As one of the leading COVID-19 vaccine manufacturers in China, Sinovac has expanded its annual production capacity to 2 billion doses and offered its inactivated vaccines to over 16 countries and regions. The Global Times reporters Hu Yuwei and Leng Shumei (GT) recently talked to Yin Weidong (Yin), the CEO of the Sinovac, to learn more about his views on vaccine's safety and effectiveness, amid frequently novel coronavirus mutations, and the company's moves in making the vaccine more globally accessible. 

​Read the interview here.​